Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí.

[Cerrar]


Artículos socios - Artículos
Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep
12/05/2016
Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A, Chiner E, Masa JF, Gonzalez M, Marín JM, Garcia-Rio F, Diaz de Atauri J, Terán J, Mayos M, de la Peña M, Monasterio C, del Campo F, Montserrat JM; Spanish Sleep And Breathing Network. Collaborators: Lumbierres M, Gomez S, Esquinas C, Rubio R, de la Torre G, Martinez-Null C, Capote F, Sánchez-Armengol A, Llombart M, Morante F, Rubio M, Corral J, Martinez MÁ, Carrizo S, Mediano O, Lores V, Álvarez M, Salord N, Hernández L, Salord N, Esquinas C.
JAMA. 2012 May 23;307(20):2161-8

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with sleep-disordered breathing, regardless of daytime symptoms, is unclear.

Objective To evaluate the effect of CPAP treatment on the incidence of hypertension or cardiovascular events in a cohort of nonsleepy patients with OSA.

Design, Setting, and Patients Multicenter, parallel-group, randomized controlled trial in 14 teaching hospitals in Spain. Between May 2004 and May 2006, 725 consecutive patients were enrolled who had an apnea-hypopnea index of 20 h−1 or greater and an Epworth Sleepiness Scale score of 10 or less (scores range from 0-24, with values <10 suggesting no daytime sleepiness). Exclusion criteria were previous cardiovascular event, physical or psychological incapacity, chronic disease, or drug or alcohol addiction. Follow-up ended in May 2009.

Intervention Patients were allocated to receive CPAP treatment or no active intervention. All participants received dietary counseling and sleep hygiene advice.

Main Outcome Measures Incidence of either systemic hypertension (taking antihypertensive medication or blood pressure greater than 140/90 mm Hg) or cardiovascular event (nonfatal myocardial infarction, nonfatal stroke, transient ischemic attack, hospitalization for unstable angina or arrhythmia, heart failure, or cardiovascular death).

Results Seven hundred twenty-three patients underwent follow-up for a median of 4 (interquartile range, 2.7-4.4) years (1 patient from each group did not receive allocated treatment); 357 in the CPAP group and 366 in the control group were included in the analysis. In the CPAP group there were 68 patients with new hypertension and 28 cardiovascular events (17 unstable angina or arrhythmia, 3 nonfatal stroke, 3 heart failure, 2 nonfatal myocardial infarction, 2 transient ischemic attack, 1 cardiovascular death). In the control group there were 79 patients with new hypertension and 31 cardiovascular events (11 unstable angina or arrhythmia, 8 nonfatal myocardial infarction, 5 transient ischemic attack, 5 heart failure, 2 nonfatal stroke). The hypertension or cardiovascular event incidence density rate was 9.20 per 100 person-years (95% CI, 7.36-11.04) in the CPAP group and 11.02 per 100 person-years (95% CI, 8.96-13.08) in the control group. The incidence density ratio was 0.83 (95% CI, 0.63-1.1; P = .20).

Conclusions In patients with OSA without daytime sleepiness, the prescription of CPAP compared with usual care did not result in a statistically significant reduction in the incidence of hypertension or cardiovascular events. However, the study may have had limited power to detect a significant difference.


Patrocinadores Neumosur
Patrocinadores Neumosur
Patrocinadores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Colaboradores Neumosur
Área de profesionales
Neumosur en los medios >>
ABC de Sevilla 31/05/2019 Virgen del Rocío: cada año 400 nuevos fumadores van al hospital para dejar el tabaco
Teleprensa.com 30/05/2019 Neumólogos abogan por dar ayuda para dejar de fumar a pacientes con enfermedades relacionadas con el tabaco
ABC de Sevilla 30/05/2019 Más de 300.000 sevillanos fuman a diario
La Vanguardia 30/05/2019 Neumólogos abogan por dar ayuda para dejar de fumar a pacientes con enfermedades relacionadas con el tabaco
Infosalus.com 30/05/2019 Neumólogos abogan por dar ayuda para dejar de fumar a pacientes con enfermedades relacionadas con el tabaco
Europa Press 30/05/2019 Neumólogos abogan por dar ayuda para dejar de fumar a pacientes con enfermedades relacionadas con el tabaco
Otra revista.com 30/05/2019 Más de 300.000 sevillanos fuman a diario
Gente Digital 30/05/2019 Neumólogos abogan por dar ayuda para dejar de fumar a pacientes con enfermedades relacionadas con el tabaco
Zamora24horas.com 21/04/2019 Investigadores detectan alteraciones en los niveles de metales en las células de enfermos de cáncer de pulmón
Diario Hoy 14/04/2019 El 13% de los fumadores del Área de Salud de Mérida padece EPOC
Newsletter Revista:
SUSCRIBE
Cargando

Espera un momento
Se está guardando la solicitud.

Cargando

Espera un momento
Se está enviando el manuscrito.